Crispr Invest Information

CRISPR Therapeutics (NASDAQ:CRSP) Stock Review: Recent Trading Trends Mar 6, 2025

Intellia Therapeutics Surpasses Q3 Earnings Expectations and Announces Progress in Gene-Editing Pipeline Nov 11, 2023